- Home
- CGBD vs EIKN Comparison
CGBD vs EIKN Comparison
Compare CGBD & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
N/A
Current Price
$15.05
Company Overview
Basic Information| Metric | CGBD | EIKN |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 913.5M | 731.6M |
| IPO Year | 2017 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CGBD | EIKN |
|---|---|---|
| Price | $11.92 | $15.05 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $13.70 | N/A |
| AVG Volume (30 Days) | 521.0K | ★ 1.1M |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | ★ 13.84% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $245,008,000.00 | N/A |
| Revenue This Year | $12.93 | N/A |
| Revenue Next Year | $3.04 | N/A |
| P/E Ratio | $10.48 | ★ N/A |
| Revenue Growth | ★ 2.55 | N/A |
| 52 Week Low | $11.55 | $13.29 |
| 52 Week High | $18.40 | $17.40 |
Technical Indicators
Market Signals| Indicator | CGBD | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 38.59 | N/A |
| Support Level | $11.87 | N/A |
| Resistance Level | $12.33 | N/A |
| Average True Range (ATR) | 0.29 | 0.00 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 22.01 | 0.00 |
Price Performance
Historical Comparison CGBD
EIKN
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.